The scrip ended 12.20 per cent higher at Rs 180.70 on the BSE. During the day, shares of the company had surged 14.6 per cent to Rs 184.55.
At the NSE, the scrip shot-up by 11.72 per cent to Rs 180.20.
Aurobindo Pharma had on Friday posted consolidated net profit of Rs 18.60 crore for the April-June quarter of 2013-14 fiscal. The Hyderabad-based firm had posted net loss of Rs 128.91 crore during the April-June quarter of 2012-13 fiscal.
Net Q1 sales of the company rose to Rs 1,699.60 crore, as against Rs 1,197.44 crore during the same period of the previous fiscal.